Science 28 May 1993: Vol. 260. no. 5112, pp. 1344 - 1348 DOI: 10.1126/science.8388127

Prev | Table of Contents | Next

Articles

SB-431542 Inhibition of Scar Formation after Filtration Surgery and Its Potential Mechanism.

Y.-q. Xiao, K. Liu, J.-f. Shen, G.-T. Xu, and W. Ye (2009)
Invest. Ophthalmol. Vis. Sci. 50, 1698-1706
 |  Abstract »  |  Full Text »  |  PDF »

Cancer-Associated Transforming Growth Factor {beta} Type II Receptor Gene Mutant Causes Activation of Bone Morphogenic Protein-Smads and Invasive Phenotype.

S. Bharathy, W. Xie, J. M. Yingling, and M. Reiss (2008)
Cancer Res. 68, 1656-1666
 |  Abstract »  |  Full Text »  |  PDF »

Expression and Regulation of the Osteoarthritis-associated Protein Asporin.

I. Kou, M. Nakajima, and S. Ikegawa (2007)
J. Biol. Chem. 282, 32193-32199
 |  Abstract »  |  Full Text »  |  PDF »

Coronary Vessel Development Is Dependent on the Type III Transforming Growth Factor {beta} Receptor.

L. A. Compton, D. A. Potash, C. B. Brown, and J. V. Barnett (2007)
Circ. Res. 101, 784-791
 |  Abstract »  |  Full Text »  |  PDF »

Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.

N. Renlund, F. H O'Neill, L. Zhang, Y. Sidis, and J. Teixeira (2007)
J. Endocrinol. 195, 95-103
 |  Abstract »  |  Full Text »  |  PDF »

Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk.

J. Skoglund, B. Song, J. Dalen, S. Dedorson, D. Edler, F. Hjern, J. Holm, C. Lenander, U. Lindforss, N. Lundqvist, et al. (2007)
Clin. Cancer Res. 13, 3748-3752
 |  Abstract »  |  Full Text »  |  PDF »

Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1.

J Skoglund, T Djureinovic, X-L Zhou, J Vandrovcova, E Renkonen, L Iselius, M L Bisgaard, P Peltomaki, and A Lindblom (2006)
J. Med. Genet. 43, e07
 |  Abstract »  |  Full Text »  |  PDF »

Chromosome Rearrangements in Canine Fibrosarcomas.

D. R. Sargan, B. S. Milne, J. A. Hernandez, P. C. M. O'Brien, M. A. Ferguson-Smith, T. Hoather, and J. M. Dobson (2005)
J. Hered. 96, 766-773
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor-{beta} (TGF-{beta}) Type I Receptor/ALK5-dependent Activation of the GADD45{beta} Gene Mediates the Induction of Biglycan Expression by TGF-{beta}.

H. Ungefroren, S. Groth, M. Ruhnke, H. Kalthoff, and F. Fandrich (2005)
J. Biol. Chem. 280, 2644-2652
 |  Abstract »  |  Full Text »  |  PDF »

Production and localization of activins and activin type IIA and IIB receptors by the human endosalpinx.

B A Refaat, A O Bahathiq, S Sockanathan, R L Stewart, M Wells, and W L Ledger (2004)
Reproduction 128, 249-255
 |  Abstract »  |  Full Text »  |  PDF »

Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells.

V. Kaartinen, M. Dudas, A. Nagy, S. Sridurongrit, M. M. Lu, and J. A. Epstein (2004)
Development 131, 3481-3490
 |  Abstract »  |  Full Text »  |  PDF »

SB-431542, a small molecule transforming growth factor-{beta}-receptor antagonist, inhibits human glioma cell line proliferation and motility.

M. D. Hjelmeland, A. B. Hjelmeland, S. Sathornsumetee, E. D. Reese, M. H. Herbstreith, N. J. Laping, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich (2004)
Mol. Cancer Ther. 3, 737-745
 |  Abstract »  |  Full Text »  |  PDF »

Vascular morphogenesis: tales of two syndromes.

D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski (2003)
Hum. Mol. Genet. 12, R97-112
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of Biglycan Gene Expression by Transforming Growth Factor-beta Requires MKK6-p38 Mitogen-activated Protein Kinase Signaling Downstream of Smad Signaling.

H. Ungefroren, W. Lenschow, W.-B. Chen, F. Faendrich, and H. Kalthoff (2003)
J. Biol. Chem. 278, 11041-11049
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of ALK-1 Signaling by the Nuclear Receptor LXRbeta.

J. Mo, S. J. Fang, W. Chen, and G. C. Blobe (2002)
J. Biol. Chem. 277, 50788-50794
 |  Abstract »  |  Full Text »  |  PDF »

Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary.

S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff (2002)
J. Clin. Endocrinol. Metab. 87, 2644-2657
 |  Abstract »  |  Full Text »  |  PDF »

Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity.

C. M. Bollard, C. Rossig, M. J. Calonge, M. H. Huls, H.-J. Wagner, J. Massague, M. K. Brenner, H. E. Heslop, and C. M. Rooney (2002)
Blood 99, 3179-3187
 |  Abstract »  |  Full Text »  |  PDF »

The Distribution of Betaglycan Protein and mRNA in Rat Brain, Pituitary, and Gonads: Implications for a Role for Betaglycan in Inhibin-Mediated Reproductive Functions.

L. A. MacConell, A. M. O. Leal, and W. W. Vale (2002)
Endocrinology 143, 1066-1075
 |  Abstract »  |  Full Text »  |  PDF »

Associated changes of lipid peroxidation and transforming growth factor {beta}1 levels in human colon cancer during tumour progression.

F Biasi, L Tessitore, D Zanetti, J C Cutrin, B Zingaro, E Chiarpotto, N Zarkovic, G Serviddio, and G Poli (2002)
Gut 50, 361-367
 |  Abstract »  |  Full Text »  |  PDF »

Integrin beta 1 Signaling Is Necessary for Transforming Growth Factor-beta Activation of p38MAPK and Epithelial Plasticity.

N. A. Bhowmick, R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses (2001)
J. Biol. Chem. 276, 46707-46713
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Retinoids on the TGF-{beta} System and Extracellular Matrix in Experimental Glomerulonephritis.

C. MORATH, C. DECHOW, I. LEHRKE, V. HAXSEN, R. WALDHERR, J. FLOEGE, E. RITZ, and J. WAGNER (2001)
J. Am. Soc. Nephrol. 12, 2300-2309
 |  Abstract »  |  Full Text »  |  PDF »

Both the Extracellular Leucine-Rich Repeat Domain and the Kinase Activity of FLS2 Are Required for Flagellin Binding and Signaling in Arabidopsis.

L. Gómez-Gómez, Z. Bauer, and T. Boller (2001)
PLANT CELL 13, 1155-1163
 |  Abstract »  |  Full Text »

Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.

Z. A. Quinn, C.-C. Yang, J. L. Wrana, and J. C. McDermott (2001)
Nucleic Acids Res. 29, 732-742
 |  Abstract »  |  Full Text »  |  PDF »

Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis.

N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld (2000)
Blood 96, 2022-2036
 |  Abstract »  |  Full Text »  |  PDF »

Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.

K. Kitamura, S.-i. Aota, R. Sakamoto, S.-I. Yoshikawa, and K. Okazaki (2000)
Blood 95, 3371-3379
 |  Abstract »  |  Full Text »  |  PDF »

Disruption of T Cell Homeostasis in Mice Expressing a T Cell-Specific Dominant Negative Transforming Growth Factor {beta} II Receptor.

P. J. Lucas, S.-J. Kim, S. J. Melby, and R. E. Gress (2000)
J. Exp. Med. 191, 1187-1196
 |  Abstract »  |  Full Text »  |  PDF »

A Deletion in the Gene for Transforming Growth Factor beta Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor beta in a Cutaneous T-Cell Lymphoma.

W. P. Schiemann, W. M. Pfeifer, E. Levi, M. E. Kadin, and H. F. Lodish (1999)
Blood 94, 2854-2861
 |  Abstract »  |  Full Text »  |  PDF »

Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-beta -induced Gene Expression.

H. Hanafusa, J. Ninomiya-Tsuji, N. Masuyama, M. Nishita, J.-i. Fujisawa, H. Shibuya, K. Matsumoto, and E. Nishida (1999)
J. Biol. Chem. 274, 27161-27167
 |  Abstract »  |  Full Text »  |  PDF »

Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-beta Superfamily.

N. P. Barbara, J. L. Wrana, and M. Letarte (1999)
J. Biol. Chem. 274, 584-594
 |  Abstract »  |  Full Text »  |  PDF »

Proliferative and Apoptotic Responses in Cancers With Special Reference To Oral Cancers.

A.R. Kamer, L. Krebs, S.A. Hoghooghi, and C. Liebow (1999)
Critical Reviews in Oral Biology & Medicine 10, 58-78
 |  Abstract »  |  Full Text »  |  PDF »

Cloning and characterization of a naturally occurring soluble form of TGF-beta type I receptor.

M. E. Choi (1999)
Am J Physiol Renal Physiol 276, F88-F95
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor-Beta 1 (TGF-beta 1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-kappa B, AP-1 and NF-AT in EL4 Cells.

S. H. Han, S. S. Yea, Y. J. Jeon, K.-H. Yang, and N. E. Kaminski (1998)
J. Pharmacol. Exp. Ther. 287, 1105-1112
 |  Abstract »  |  Full Text »

Smad2 Overexpression Enhances Smad4 Gene Expression and Suppresses CBFA1 Gene Expression in Osteoblastic Osteosarcoma ROS17/2.8 Cells and Primary Rat Calvaria Cells.

J. Li, K. Tsuji, T. Komori, K. Miyazono, J. L. Wrana, Y. Ito, A. Nifuji, and M. Noda (1998)
J. Biol. Chem. 273, 31009-31015
 |  Abstract »  |  Full Text »  |  PDF »

Physical and Functional Interactions between Type I Transforming Growth Factor beta  Receptors and Balpha , a WD-40 Repeat Subunit of Phosphatase 2A.

I. Griswold-Prenner, C. Kamibayashi, E. M. Maruoka, M. C. Mumby, and R. Derynck (1998)
Mol. Cell. Biol. 18, 6595-6604
 |  Abstract »  |  Full Text »

Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2.

M. Macias-Silva, P. A. Hoodless, S. J. Tang, M. Buchwald, and J. L. Wrana (1998)
J. Biol. Chem. 273, 25628-25636
 |  Abstract »  |  Full Text »  |  PDF »

Role of Transforming Growth Factor (TGF)-{beta} Type I and TGF-{beta} Type II Receptors in the TGF-{beta}1-Regulated Gene Expression in Pituitary Prolactin-Secreting Lactotropes.

D. K. Sarkar, M. Pastorcic, A. De, M. Engel, H. Moses, and M. B. Ghasemzadeh (1998)
Endocrinology 139, 3620-3628
 |  Abstract »  |  Full Text »  |  PDF »

Basic Guide to the Mechanisms of Antiestrogen Action.

J. I. Macgregor and V. C. Jordan (1998)
Pharmacol. Rev. 50, 151-196
 |  Abstract »  |  Full Text »  |  PDF »

Localization of Transforming Growth Factor-b1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma Tissues.

M. J. Gerdes, M. Larsen, L. McBride, T. D. Dang, B. Lu, and D. R. Rowley (1998)
J. Histochem. Cytochem. 46, 379-388
 |  Abstract »  |  Full Text »

Regulation of Clusterin Gene Expression by Transforming Growth Factor beta.

G. Jin and P. H. Howe (1997)
J. Biol. Chem. 272, 26620-26626
 |  Abstract »  |  Full Text »  |  PDF »

Inhibin Interferes with Activin Signaling at the Level of the Activin Receptor Complex in Chinese Hamster Ovary Cells.

J. W. M. Martens, J. P. de Winter, M. A. Timmerman, A. McLuskey, R. H. N. van Schaik, A. P. N. Themmen, and F. H. de Jong (1997)
Endocrinology 138, 2928-2936
 |  Abstract »  |  Full Text »  |  PDF »

The Type II Transforming Growth Factor-beta Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues.

S. Lawler, X.-H. Feng, R.-H. Chen, E. M. Maruoka, C. W. Turck, I. Griswold-Prenner, and R. Derynck (1997)
J. Biol. Chem. 272, 14850-14859
 |  Abstract »  |  Full Text »  |  PDF »

Bovine Activin Receptor Type IIB Messenger Ribonucleic Acid Displays Alternative Splicing Involving a Sequence Homologous to Src-Homology 3 domain Binding Sites.

J.-F. Ethier, J. G. Lussier, and D. W. Silversides (1997)
Endocrinology 138, 2425-2434
 |  Abstract »  |  Full Text »  |  PDF »

A Novel Role of Follistatin, an Activin-binding Protein, in the Inhibition of Activin Action in Rat Pituitary Cells. ENDOCYTOTIC DEGRADATION OF ACTIVIN AND ITS ACCELERATION BY FOLLISTATIN ASSOCIATED WITH CELL-SURFACE HEPARAN SULFATE.

O. Hashimoto, T. Nakamura, H. Shoji, S. Shimasaki, Y. Hayashi, and H. Sugino (1997)
J. Biol. Chem. 272, 13835-13842
 |  Abstract »  |  Full Text »  |  PDF »

Biosynthesis of the Type I and Type II TGF-beta Receptors. IMPLICATIONS FOR COMPLEX FORMATION.

R. G. Wells, H. Yankelev, H. Y. Lin, and H. F. Lodish (1997)
J. Biol. Chem. 272, 11444-11451
 |  Abstract »  |  Full Text »  |  PDF »

The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line.

A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin (1997)
Endocrinology 138, 1498-1505
 |  Abstract »  |  Full Text »  |  PDF »

A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis.

C Chang, P. Wilson, L. Mathews, and A Hemmati-Brivanlou (1997)
Development 124, 827-837
 |  Abstract »  |  PDF »

A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System.

M. Ryden, T. Imamura, H. Jornvall, N. Belluardo, I. Neveu, M. Trupp, T. Okadome, P. ten Dijke, and C. F. Ibanez (1996)
J. Biol. Chem. 271, 30603-30609
 |  Abstract »  |  Full Text »  |  PDF »

Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation..

Y Mishina, R Rey, M J Finegold, M M Matzuk, N Josso, R L Cate, and R R Behringer (1996)
Genes & Dev. 10, 2577-2587
 |  Abstract »  |  PDF »

Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells.

J. Wang, W. Han, E. Zborowska, J. Liang, X. Wang, J. K.V. Willson, L. Sun, and M. G. Brattain (1996)
J. Biol. Chem. 271, 17366-17371
 |  Abstract »  |  Full Text »  |  PDF »

Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-beta (TGF-beta ) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-beta in Vascular Wall Cells in Primary Culture.

H. Yamamoto, H. Ueno, A. Ooshima, and A. Takeshita (1996)
J. Biol. Chem. 271, 16253-16259
 |  Abstract »  |  Full Text »  |  PDF »

Fetuin/alpha 2-HS Glycoprotein Is a Transforming Growth Factor-beta Type II Receptor Mimic and Cytokine Antagonist.

M. Demetriou, C. Binkert, B. Sukhu, H. C. Tenenbaum, and J. W. Dennis (1996)
J. Biol. Chem. 271, 12755-12761
 |  Abstract »  |  Full Text »  |  PDF »

Ligand-independent Activation of Transforming Growth Factor (TGF) beta Signaling Pathways by Heteromeric Cytoplasmic Domains of TGF-beta Receptors.

X.-H. Feng and R. Derynck (1996)
J. Biol. Chem. 271, 13123-13129
 |  Abstract »  |  Full Text »  |  PDF »

Repression of Transforming Growth Factor beta1 Protein by Antisense Oligonucleotide-induced Increase of Adrenal Cell Differentiated Functions.

C. Le Roy, P. Leduque, P. M. Dubois, J. M. Saez, and D. Langlois (1996)
J. Biol. Chem. 271, 11027-11033
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-beta.

M. Saitoh, H. Nishitoh, T. Amagasa, K. Miyazono, M. Takagi, and H. Ichijo (1996)
J. Biol. Chem. 271, 2769-2775
 |  Abstract »  |  Full Text »  |  PDF »

Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis..

Y Mishina, A Suzuki, N Ueno, and R R Behringer (1995)
Genes & Dev. 9, 3027-3037
 |  Abstract »  |  PDF »

Activin Increases Phosphorylation and Decreases Stability of the Transcription Factor Pit-1 in MtTW15 Somatotrope Cells.

D. Gaddy-Kurten and W. W. Vale (1995)
J. Biol. Chem. 270, 28733-28739
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex.

X.-H. Feng, E. H. Filvaroff, and R. Derynck (1995)
J. Biol. Chem. 270, 24237-24245
 |  Abstract »  |  Full Text »  |  PDF »

Cooperative Binding of Transforming Growth Factor (TGF)-[IMAGE]2 to the Types I and II TGF-[IMAGE] Receptors.

C. Rodriguez, F. Chen, R. A. Weinberg, and H. F. Lodish (1995)
J. Biol. Chem. 270, 15919-15922
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Transforming Growth Factor Type III Receptor in Vascular Endothelial Cells Increases Their Responsiveness to Transforming Growth Factor [IMAGE]2.

S. Sankar, N. Mahooti-Brooks, M. Centrella, T. L. McCarthy, and J. A. Madri (1995)
J. Biol. Chem. 270, 13567-13572
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor-[IMAGE] Receptors.

R.-H. Chen, H. L. Moses, E. M. Maruoka, R. Derynck, and M. Kawabata (1995)
J. Biol. Chem. 270, 12235-12241
 |  Abstract »  |  Full Text »  |  PDF »

Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription.

T. Brand and M. D. Schneider (1995)
J. Biol. Chem. 270, 8274-8284
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor beta Activation of p44[IMAGE] in Proliferating Cultures of Epithelial Cells.

M. T. Hartsough and K. M. Mulder (1995)
J. Biol. Chem. 270, 7117-7124
 |  Abstract »  |  Full Text »  |  PDF »

Signaling Activity of Homologous and Heterologous Transforming Growth Factor-beta Receptor Kinase Complexes.

D. Vivien, L. Attisano, and J. Massagué (1995)
J. Biol. Chem. 270, 7134-7141
 |  Abstract »  |  Full Text »  |  PDF »

Transforming Growth Factor-beta1 Induction of Novel Extracellular Matrix Proteins That Trigger Resistance to Tumor Necrosis Factor Cytotoxicity in Murine L929 Fibroblasts.

N.-S. Chang and N. S. Chang (1995)
J. Biol. Chem. 270, 7765-7772
 |  Abstract »  |  Full Text »  |  PDF »

Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism.

J. Xu, K. McKeehan, K. Matsuzaki, and W. L. McKeehan (1995)
J. Biol. Chem. 270, 6308-6313
 |  Abstract »  |  Full Text »  |  PDF »

Distribution and Characterization of Specific Cellular Binding Proteins for Bone Morphogenetic Protein-2.

S. Iwasaki, N. Tsuruoka, A. Hattori, M. Sato, M. Tsujimoto, and M. Kohno (1995)
J. Biol. Chem. 270, 5476-5482
 |  Abstract »  |  Full Text »  |  PDF »

Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-beta Receptor.

M. Kawabata, A. Chytil, and H. L. Moses (1995)
J. Biol. Chem. 270, 5625-5630
 |  Abstract »  |  Full Text »  |  PDF »

The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-beta Receptor.

H. Y. Lin, A. Moustakas, P. Knaus, R. G. Wells, Y. I. Henis, and H. F. Lodish (1995)
J. Biol. Chem. 270, 2747-2754
 |  Abstract »  |  Full Text »  |  PDF »

GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A.

A. Moustakas, T. Takumi, H. Y. Lin, and H. F. Lodish (1995)
J. Biol. Chem. 270, 765-769
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of type I receptors for transforming growth factor-beta and activin.

P ten Dijke, H Yamashita, H Ichijo, P Franzen, M Laiho, K Miyazono, and C. Heldin (1994)
Science 264, 101-104
 |  Abstract »  |  PDF »

The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-beta superfamily.

T Xie, A. Finelli, and R. Padgett (1994)
Science 263, 1756-1759
 |  Abstract »  |  PDF »

The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms..

D M Kingsley (1994)
Genes & Dev. 8, 133-146
 |  PDF »

Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins.

A Feijen, M. Goumans, and A. van den Eijnden-van Raaij (1994)
Development 120, 3621-3637
 |  Abstract »  |  PDF »

Multiple requirements for the receptor serine/threonine kinase thick veins reveal novel functions of TGF beta homologs during Drosophila embryogenesis.

M Affolter, D Nellen, U Nussbaumer, and K Basler (1994)
Development 120, 3105-3117
 |  Abstract »  |  PDF »

A transforming growth factor beta type I receptor that signals to activate gene expression.

C. Bassing, J. Yingling, D. Howe, T Wang, W. He, M. Gustafson, P Shah, P. Donahoe, and X. Wang (1994)
Science 263, 87-89
 |  Abstract »  |  PDF »

Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.

E. Filvaroff, R Ebner, and R Derynck (1994)
Development 120, 1085-1095
 |  Abstract »  |  PDF »

The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1.

S Lawler, A. Candia, R Ebner, L Shum, A. Lopez, H. Moses, C. Wright, and R Derynck (1994)
Development 120, 165-175
 |  Abstract »  |  PDF »

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct.

W. Baarends, M. van Helmond, M Post, P. van der Schoot, J. Hoogerbrugge, J. de Winter, J. Uilenbroek, B Karels, L. Wilming, J. Meijers, et al. (1994)
Development 120, 189-197
 |  Abstract »  |  PDF »

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

R Ebner, R. Chen, S Lawler, T Zioncheck, and R Derynck (1993)
Science 262, 900-902
 |  Abstract »  |  PDF »

Sorting Nexin 6, a Novel SNX, Interacts with the Transforming Growth Factor-beta Family of Receptor Serine-Threonine Kinases.

W. T. Parks, D. B. Frank, C. Huff, C. Renfrew Haft, J. Martin, X. Meng, M. P. de Caestecker, J. G. McNally, A. Reddi, S. I. Taylor, et al. (2001)
J. Biol. Chem. 276, 19332-19339
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products